Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics examines how variations in a single gene influence drug effects, while pharmacogenomics takes a broader approach by studying how genetic variants across populations affect drug responses. Both fields aim to explain why individuals experience different levels of drug efficacy or adverse reactions to the same medication.

Studies show that up to 75% of the variability in drug metabolism can be attributed to inherited genetic differences. Genetic variations in drug-metabolizing enzymes cause some individuals to metabolize drugs more quickly or slowly than others, directly influencing the drug's effectiveness and safety profile.

Genetic differences can affect drug metabolism through variations in cytochrome P450 enzymes, drug transporters, and drug receptors. These alterations influence how quickly drugs are metabolized, how they move through cells, and how effectively they interact with their molecular targets, ultimately determining drug efficacy and toxicity.

Environmental factors such as diet, age, infections, and concurrent drug use interact with genetic factors to influence drug metabolism and interactions with molecular targets. This combination of genetic and environmental influences explains why two patients with identical genetic profiles may still respond differently to the same medication.

Advances in genomic technologies, such as genome-wide screening and DNA chips, allow scientists to identify numerous genetic variants influencing drug processing. These technologies enable researchers to pinpoint key genetic markers and develop personalized drug treatments tailored to an individual's genetic profile.

By identifying genetic markers that influence drug responses, clinicians can prescribe safer and more effective medications tailored to each patient's genetic makeup. This personalized approach reduces the risk of adverse drug reactions and improves therapeutic outcomes by ensuring patients receive the most appropriate drug at the correct dose.

Genetic variability in drug-metabolizing enzymes, transporters, and receptors causes individuals to process and respond to drugs differently. Some people may metabolize a drug too quickly, reducing its effectiveness, while others metabolize it slowly, leading to toxic accumulation and adverse reactions.